Athletigen Company
Delivering world-class DNA analysis techology to optimize performance in elite athletes and develop precision products
Technology:
P4 Medicine
Headquarters:
Canada
Acquisitions Number:
1
Funding Status:
Seed
Founded Date:
2014-03-01
Last Funding Type:
Seed
Investors Number:
3
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Total Funding:
$1.6M
Industry:
P4 Medicine
Investor Type:
For Profit